Latest Insulet News & Updates

See the latest news and media coverage for Insulet. We track all announcements, press releases, and industry mentions in real time, all in one place.

Insulet

Maker of tubeless insulin delivery systems

insulet.com

Headquarters: Acton, United States
Company type: Public company
Number of employees: 5,000–5,600
Industry: Medical Equipment, Supplies & Distribution

Last updated October 8

Latest news about Insulet

In short: Insulet faced an overturned trade secret verdict, product recall fallout, and strong Q2 results despite lowered guidance.

Company announcements

August 5 Insulet

Insulet reports Q2 2026 earnings with $801.7M revenue

Adjusted EPS grew 41.5% to $1.66, while operating margin expanded to 19.3%. The company raised full-year guidance amid strong international growth.

May 26 Insulet

Insulet initiates voluntary correction for certain Omnipod pods

The correction addresses a manufacturing issue that could cause insulin under-delivery, affecting approximately 7 million pods globally.

May 6 Insulet

Insulet reports Q1 2026 results

Revenue reaches $761.7M, up 33.9%; raises full-year guidance. Launches Omnipod 5 in Middle East, updates algorithm.

March 12 Insulet

Insulet initiates voluntary correction for certain Omnipod 5 Pods

A manufacturing issue may cause insulin leaks, leading to high blood glucose. Customers can check lots and get free replacements. Other products remain safe.

Media coverage

October 8 Benzinga

Insulet Reports Q2 2026 Results: Full Earnings Call Transcript - Insulet (NASDAQ:PODD)

Insulet (NASDAQ:PODD) released second-quarter financial results and hosted an earnings call on...

September 29 Ad Hoc News

Insulet stock falls 1.13 percent as guidance concerns persist

Insulet stock delivered USD 801.70 million in Q2 2026 revenue, up 23.50 percent year over year. Full-year growth guidance is 20.00 to 22.00 percent after...

September 11 Ad Hoc News

The Insulet stock struggles with capped US guidance and board changes after strong Q2 figures

The Insulet stock (ISIN US45784P1012) stands in September 2026 in the tension field between a clear profit increase in the second ...

August 24 Yahoo Finance

Can PODD Sustain Growth After Its 2026 Guidance Reset and Q2 Beat?

Insulet's Q2 beat and stronger margins contrast with a 2026 growth reset, putting U.S. Type 2 retention at the center of its ...

Never miss news about Insulet

Track Insulet and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.